Welcome!

XML Authors: Pat Romanski, Kira Makagon, Yeshim Deniz, Carmen Gonzalez, Roger Strukhoff

News Feed Item

Digital Pathology Market 2014-2018 Global Research Report (Slide Scanners, Analytics, Delivery Modes, Whole Slide Image Storage) Now Available With ReportsnReports.com

DALLAS, August 11, 2014 /PRNewswire/ --

The global digital pathology market is expected to grow at 11.8% CAGR to reach an estimated $437 million by 2018. In 2013, the North American market was valued at $128.9 million and accounted for the largest share of the global digital pathology market, followed by Europe and Asia. The North American market is expected to grow at a healthy growth rate over the next five years. This high growth can be attributed to the favorable reimbursement scenario in the U.S. and the use of digital pathology to improve the quality of cancer diagnosis in Canada. However, lack of FDA approvals for digital pathology to be used for primary diagnosis acts as a major barrier for the North American market.

The European region has gained momentum for digital pathology. Some of the European countries have witnessed successful pathology projects which are likely to lead to higher adoption of digital pathology in these countries. Furthermore, Europe hosts various digital pathology conferences that aim to bring professionals under one roof and bring to light the ongoing developments in digital pathology. However, the Asian market, slated at an estimated CAGR of 13.7%, will experience the highest growth in the digital pathology market. The rise in awareness of digital pathology and its benefits, collaborative efforts by players, and federal health departments encouraging the use of digital pathology to improve the quality of cancer diagnosis are some of the factors driving the growth of the Asian market.

The major players in this market include 3DHistech (Hungary), Leica Biosystems (Germany), Ventana Medical Systems (U.S.), Hamamatsu Photonics K.K. (Japan), Mikroscan Technologies (U.S.), Definiens AG (Germany), Visiopharm (Denmark), and Indica Labs (U.S.). Rising Prevalence of Cancer, Improvement in Lab Efficiency, Drug Development, Increasing Use of Companion Diagnostics and Ease of Consultation Enabled by Digital Pathology are some of the major drivers of this industry. Order your copy of this report for US $ 4650 (single user) at http://www.reportsnreports.com/Purchase.aspx?name=195916. You can also inquire for a discount on this report through http://www.reportsnreports.com/contacts/Discount.aspx?name=195916.

High Cost of Digital Pathology Systems, Regulatory Concerns and Conservative Outlook of Pathologists are some of the industry restraints discussed in this digital pathology market research report. Opportunities that new entrants as well as market players can look forward to in this industry include Digital Pathology to Help Combat the Shortage of Pathologists, Affordable Scanners for Private Pathology Practices, Biopharmaceutical and Drug toxicology Studies, Personalized Medicine and Digital Pathology to Aid Collaborations Between Asia and the West. By application, the global digital pathology market has been studied in this research based on human pathology (Pharmaceutical & Biotechnology Companies, Hospitals / Reference Laboratories / Academic Medical Centers (AMC) and Training and Education) as well as animal pathology (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes and Contract Research Organizations). The geographic analysis chapter of the report covers following major points:

1 Introduction

2 North America

2.1 U.S.

   2.1.1 Favorable Reimbursement Scenario for Digital Pathology in the U.S. to Boost the Market

2.2 Canada

  2.2.1 Embracing Digital Pathology to Improve the Quality of Healthcare in Canada

3 Europe

3.1 U.K.

  3.1.1 Technological Developments in the U.K. to Propel the Market

  3.1.2 Conferences in the U.K. to Boost the Market

3.2 Germany

  3.2.1 Conferences in Germany to Trigger Growth

3.3 Italy

  3.3.1 Successful Digital Pathology Projects in Italy

3.4 France

  3.4.1 Use of Digital Pathology in the Pharmaceutical Industry to Boost the Market in France

3.5 Spain

  3.5.1 Adoption of Digital Pathology to Improve Quality of Healthcare

3.6 Denmark

  3.6.1 Alarming Rise in Prevalence of Cancer to Boost the Market in Denmark

3.7 Norway

  3.7.1 Digital Pathology Revolution in Norway to Propel Market Growth

3.8 Sweden

  3.8.1 Conferences in Sweden to Boost the Market

  3.8.2 Positive Funding Scenario in Sweden to Focus on innovation

3.9 Rest of Europe (ROE)

3.9.1 Digital Pathology Gaining Momentum in Netherlands

7.4 Asia

4.1 China

  4.1.1 Collaborations in China to Boost the Market Growth

  4.1.2 Ministry of Health in China Encourages Use of Digital Pathology

4.2 Japan

  4.2.1 Focus on Stomach Cancer Diagnosis to Propel the Market in Japan

4.3 India

  4.3.1 Digital Pathology Gaining Momentum in India

4.4 Rest of Asia (ROA)

 4.4.1 Bilateral Agreements Aimed to Increase Awareness in Pakistan

5 Rest of the World (ROW)

 5.1 Latin America

  5.1.1 Players Eyeing Brazil As An Attractive Market

5.2 Africa

 5.2.1 Strategies By Key Players to Aid Growth in Africa

5.3 Russia

 5.3.1 Increasing Popularity of Digital Pathology As A Cost-Effective Solution to Help Propel the Market in Russia

5.4 Middle East

  5.4.1 Exhibitions in the Middle East to Increase Awareness

5.5 Pacific Countries

  5.5.1 Patients in the Pacific Countries to Receive Better and Timely Diagnosis Due to Digital Pathology

Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas, Europe, BRIC, Japan & RoW) - Trends & Forecast to 2018 is a April 2014 research report of 251 pages. The report provides qualitative insights about key market shares, growth rates, and market drivers for all important sub-segments. It maps the market sizes and growth rates of each sub-segment and identifies the segments poised for rapid growth in each of the 20 geographic and regional segments. The report also includes the company profiles of market leaders. The profiles include financial performance, product portfolios, and market developments for each company. The report also provides a competitive landscape of these market leaders and identifies the key growth strategies in this market. Companies like Abbott Laboratories, Inc., Agilent Technologies, Biogenex Laboratories, Bio Sb., Cell Signalling Technology, Inc., Danaher Corporation, Life Technologies, Roche, Sigma Aldrich and Thermo Fisher Scientific are profiled in this research available at http://www.reportsnreports.com/reports/280675-tissue-diagnostics-market-by-technology-immunohistochemistry-in-situ-hybridization-digital-pathology-workflow-special-staining-disease-breast-cancer-gastric-cancer-lymphoma-prostate-cancer-non-small-cell-lung-cancer-and-others-product-instruments.html .

Digital Pathology Insights: Imaging Technologies, Expert Perspectives, Standardization, and Current Outlooks is a May 2014 market research report of 145 pages. A brief overview of the digital pathology market will cover identified drivers and obstacles as well as current forecasts. The FDA and several standards organizations are profiled with regard to activities that may impact the furtherance of this field. Included in this section is an exclusive interview with Craig Revie, Chair of the International Color Consortium's Medical Imaging Working Group and project coordinator for the development of a calibration system for digital microscopes.

Companies featured in this report include: 3DHISTECH, Applied Spectral Imaging, Carl Zeiss Microscopy GmbH, DigiPath Corp, FFEI Ltd., Huron Technologies, Nikon Instruments, PerkinElmer and Philips Digital Pathology Solutions. These companies have provided valuable insights as to the evolution of digital pathology within their businesses, the details of their current imaging systems, strategies, and techniques, as well as their individual perspectives on the establishment of standards in digital pathology, the challenges the field may face and the benefits that await as a digital environment becomes commonplace in pathology. Interviews with the expert company representatives are also included in the report available at http://www.reportsnreports.com/reports/286913-digital-pathology-insights-imaging-technologies-expert-perspectives-standardization-and-current-outlooks.html .

About Us 

ReportsnReports.com is an online market research reports library of 450,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.

Contact: 

Priyank Tiwari

TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252

Tel: +1-888-391-5441
[email protected]

Connect With Us on: 

Facebook: https://www.facebook.com/pages/ReportsnReports/191441427571689

LinkedIn: www.linkedin.com/company/reportsnreports

Twitter: https://twitter.com/marketsreports

Pinterest: www.pinterest.com/comeonseo/reportsnreports/

RSS/Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml


More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.